These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 12417750

  • 21. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype.
    Shao Q, Wang H, McLachlan E, Veitch GI, Laird DW.
    Cancer Res; 2005 Apr 01; 65(7):2705-11. PubMed ID: 15805269
    [Abstract] [Full Text] [Related]

  • 22. Small interfering RNA for experimental cancer therapy.
    Tong AW, Zhang YA, Nemunaitis J.
    Curr Opin Mol Ther; 2005 Apr 01; 7(2):114-24. PubMed ID: 15844618
    [Abstract] [Full Text] [Related]

  • 23. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q, Kang Q, Song WX, Luu HH, Luo X, An N, Luo J, Deng ZL, Jiang W, Yin H, Chen J, Sharff KA, Tang N, Bennett E, Haydon RC, He TC.
    Gene; 2007 Jun 15; 395(1-2):160-9. PubMed ID: 17449199
    [Abstract] [Full Text] [Related]

  • 24. Knock-down of gene expression in hematopoietic cells.
    Scherr M, Venturini L, Eder M.
    Methods Mol Biol; 2009 Jun 15; 506():207-19. PubMed ID: 19110629
    [Abstract] [Full Text] [Related]

  • 25. Efficient selection of silenced primary cells by flow cytometry.
    Martínez-Ferrandis JI, Soriano MA, Martínez-Romero A, Herrera G, Cervantes A, O'Connor JE, Knecht E, Armengod ME.
    Cytometry A; 2007 Aug 15; 71(8):599-604. PubMed ID: 17458885
    [Abstract] [Full Text] [Related]

  • 26. Development of new EBV-based vectors for stable expression of small interfering RNA to mimick human syndromes: application to NER gene silencing.
    Biard DS, Despras E, Sarasin A, Angulo JF.
    Mol Cancer Res; 2005 Sep 15; 3(9):519-29. PubMed ID: 16179499
    [Abstract] [Full Text] [Related]

  • 27. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H.
    Gene Ther; 2003 Nov 15; 10(24):2046-50. PubMed ID: 14566364
    [Abstract] [Full Text] [Related]

  • 28. Interference of hepatitis A virus replication by small interfering RNAs.
    Kanda T, Kusov Y, Yokosuka O, Gauss-Müller V.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):341-5. PubMed ID: 15120607
    [Abstract] [Full Text] [Related]

  • 29. [Construction of a retroviral vector for RNA interference targeting human telomerase reverse transcriptase].
    Wang QS, Wang XL, Li H, Wang QY, Wang QY, Yang GX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec 28; 26(12):1715-9. PubMed ID: 17259104
    [Abstract] [Full Text] [Related]

  • 30. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
    Xu Y, Linde A, Larsson O, Thormeyer D, Elmen J, Wahlestedt C, Liang Z.
    Biochem Biophys Res Commun; 2004 Apr 09; 316(3):680-7. PubMed ID: 15033453
    [Abstract] [Full Text] [Related]

  • 31. [The construction and identification of siRNA expression vector against hypoxia inducible factor -1 alpha in vitro].
    He LF, Chen KZ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 09; 10(1):60-4. PubMed ID: 18289474
    [Abstract] [Full Text] [Related]

  • 32. Designing and utilization of siRNAs targeting RNA binding proteins.
    Kim DH, Behlke M, Rossi JJ.
    Methods Mol Biol; 2008 Feb 09; 488():367-81. PubMed ID: 18982303
    [Abstract] [Full Text] [Related]

  • 33. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
    Yang XY, Lai XG, Zhang Y, Pei JM, Yang AG, Zhou SS.
    Ai Zheng; 2006 Jul 09; 25(7):805-10. PubMed ID: 16831268
    [Abstract] [Full Text] [Related]

  • 34. RNA interference mediated in human primary cells via recombinant baculoviral vectors.
    Nicholson LJ, Philippe M, Paine AJ, Mann DA, Dolphin CT.
    Mol Ther; 2005 Apr 09; 11(4):638-44. PubMed ID: 15771966
    [Abstract] [Full Text] [Related]

  • 35. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP, Shen GX.
    Br J Dermatol; 2005 Oct 09; 153(4):715-24. PubMed ID: 16181451
    [Abstract] [Full Text] [Related]

  • 36. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I, Cho BR, Kim D, Miyagawa S, Kubo T, Kim JY, Park CG, Hwang WS, Lee JS, Ahn C.
    J Biotechnol; 2005 Nov 21; 120(3):251-61. PubMed ID: 16095743
    [Abstract] [Full Text] [Related]

  • 37. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ, Rossi JJ.
    Methods Enzymol; 2005 Nov 21; 392():218-26. PubMed ID: 15644184
    [Abstract] [Full Text] [Related]

  • 38. Transposon-based RNAi delivery system for generating knockdown cell lines.
    Heggestad AD, Notterpek L, Fletcher BS.
    Biochem Biophys Res Commun; 2004 Apr 09; 316(3):643-50. PubMed ID: 15033448
    [Abstract] [Full Text] [Related]

  • 39. Baculovirus-mediated gene silencing in insect cells using intracellularly produced long double-stranded RNA.
    Huang Y, Deng F, Hu Z, Vlak JM, Wang H.
    J Biotechnol; 2007 Feb 01; 128(2):226-36. PubMed ID: 17112616
    [Abstract] [Full Text] [Related]

  • 40. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
    Ko K, Furukawa K, Takahashi T, Urano T, Sanai Y, Nagino M, Nimura Y, Furukawa K.
    Oncogene; 2006 Nov 02; 25(52):6924-35. PubMed ID: 16862187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.